NCT03010631已完成3 期
Comparative Pharmacokinetics and Food-Effect Bioavailability of a Sprinkle Formulation of Lubiprostone After Oral Administration in Healthy Volunteers
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 49
- 试验地点
- 2
- 主要终点
- Cohort 1: Maximum Observed Concentration (Cmax) of M3 Metabolite
研究概览
简要总结
A study to compare the pharmacokinetics and food-effect bioavailability of sprinkle formulation of lubiprostone, as compared to lubiprostone capsules in healthy volunteers.
详细描述
To compare the pharmacokinetics of the sprinkle formulation of lubiprostone, as compared to lubiprostone capsules and to determine the effect of food on the bioavailability and plasma pharmacokinetics of lubiprostone sprinkle.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Is male or female, between 18 and 55 years of age, inclusive.
- •Has a 12-lead electrocardiogram (ECG) within normal limits and is in good health based upon review of medical history, physical examination results, vital signs (within normal range), and normal laboratory profile for both blood and urine.
排除标准
- •Has an active or recent history of alcoholism or drug addiction (within 1 year prior)
- •Is a smoker or has a recent history of smoking (within 6 months)
- •Routinely consumes food known to alter drug metabolism (i.e., grapefruit juice, coffee, tea, cola, chocolate, cocoa, or other caffeine or methyl-xanthine containing foods or beverages) and/or cannot refrain from these items
- •Has donated blood within 3 months
- •Has a medical/surgical condition that might interfere with the absorption, distribution, metabolism, or excretion of the study medication.
结局指标
主要结局
Cohort 1: Maximum Observed Concentration (Cmax) of M3 Metabolite
时间窗: 1 day
Cohort 1: Area Under the Concentration-time Curve (AUC) From Hour 0 to the Last Measurable Concentration (AUC0-t) of M3 Metabolite
时间窗: 1 day
次要结局
- Cohort 2: Maximum Observed Concentration (Cmax) of M3 Metabolite in Fed vs Fasted Conditions(1 day)
- Cohort 2: Total Exposure (AUC0-t) of M3 With Administration of Sprinkle Lubiprostone Under Fed Versus (vs) Fasted Condition(1 day)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male VolunteersHealthyNCT02172209Boehringer Ingelheim14
已完成
1 期
Comparative Bioavailability Study of BIA 9-1067 25 mg CapsulesParkinsonNCT02071823Bial - Portela C S.A.12
已完成
1 期
Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy SubjectsHealthy VolunteerNCT04204629Hanmi Pharmaceutical Company Limited25
已完成
Unknown
Pharmacokinetic study of food ingredientHealthy subjectsJPRN-UMIN000049201M&I Science CORP.5
已完成
1 期
A Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941HealthyPharmacokinetics of ASP1941NCT01674777Astellas Pharma Inc30